OT-82, a novel anticancer drug candidate that targets the strong dependence of hematological malignancies on NAD biosynthesis

MLA

Korotchkina, L., et al. OT-82, a Novel Anticancer Drug Candidate That Targets the Strong Dependence of Hematological Malignancies on NAD Biosynthesis. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1157337130&authtype=sso&custid=ns315887.

APA

Korotchkina, L., Kazyulkin, D., Komarov, P., Polinsky, A., Andrianova, E., Joshi, S., Gupta, M., Vujcic, S., Kononov, E., Toshkov, I., Tian, Y., Krasnov, P., Chernov, M., Veith, J., Antoch, M., Middlemiss, S., Somers, K., Lock, R., Norris, M., … Gudkov, A. (2020). OT-82, a novel anticancer drug candidate that targets the strong dependence of hematological malignancies on NAD biosynthesis.

Chicago

Korotchkina, L, D Kazyulkin, Pg Komarov, A Polinsky, El Andrianova, S Joshi, M Gupta, et al. 2020. “OT-82, a Novel Anticancer Drug Candidate That Targets the Strong Dependence of Hematological Malignancies on NAD Biosynthesis.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1157337130&authtype=sso&custid=ns315887.